The present invention includes compositions and methods for treating arthriticjoints found in patients with autoinflammation, e.g., systemic onset juvenileidiopathic arthritis, by administering at the site of inflammation atherapeutically effective amount of at least one agent that reduces or blocksthe bioavailability of interleukin-1.beta..